Alongside this, researchers and pharmaceutical companies are accelerating development of dual- and triple-agonist candidates that combine GLP-1 effects with other hormone pathways, aiming to treat diabetes, obesity, and liver or kidney complications with a single medicine, thus marking a clear trend toward integrated metabolic-syndrome therapy
Persistent nausea, reduced appetite, and altered eating patterns can compromise intake of essential nutrients
However, statistical heterogeneity was low, and the sensitivity analysis showed robust results
[DOI] [PubMed] [Google Scholar] 7.Stefan N, Yki-Jrvinen H, Neuschwander-Tetri BA
They may then gradually increase the dose over time
Inhibition of tyrosinase activity and melanine pigmentation by 2-hydroxytyrosol